Chimin(SH:603222) Shang Hai Zheng Quan Bao·2025-09-10 19:10Core Viewpoint - The stock of Jimin Health Management Co., Ltd. has experienced abnormal trading fluctuations, with a cumulative closing price deviation exceeding 20% over three consecutive trading days, indicating potential market risks [2][5][9]. Group 1: Stock Trading Abnormalities - The company's stock price increased by a cumulative deviation of 75.32% over the past 30 trading days, suggesting significant volatility that diverges from the company's operational performance [2][9]. - The stock experienced a cumulative closing price deviation of over 20% on September 8, 9, and 10, 2025, qualifying as an abnormal trading situation under the Shanghai Stock Exchange rules [5][9]. Group 2: Company Verification and Response - The company conducted a self-examination and confirmed that there have been no significant changes in its main business or external operating environment, and no undisclosed major events exist [6][7]. - The controlling shareholder disclosed a share reduction plan on September 5, 2025, but no other major transactions or restructuring activities were reported [3][6]. Group 3: Financial Performance - For the first half of 2025, the company reported a net loss of 52.70 million yuan, a decline compared to the same period last year [9].